查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球麻醉蒸發器市場 - 2023-2030
市場調查報告書
商品編碼
1374841

全球麻醉蒸發器市場 - 2023-2030

Global Anaesthesia Vaporizer Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

麻醉蒸發器用於蒸發液體麻醉劑並向患者輸送受控量的麻醉劑。有三種類型的濃度校準蒸發器可變旁路、加熱混合器和電子控制蒸汽盒。這些設備用於手術室、急診室、產房、創傷科、門診手術中心以及任何需要吸入劑的區域。在絕大多數情況下，蒸發器將安裝在麻醉機上；然而，汽化器也可以透過使用特殊的安裝塊與心肺旁路控制台相關聯。

蒸發器是麻醉設備的重要組成部分。為了確保充分使用這些設備，需要了解生理學和物理學。及時識別蒸發器功能問題也很重要，因為這將減少患者可能暴露於輕度麻醉和疼痛的時間。

市場動態：促進因素與限制因素

科技進步的崛起

麻醉蒸發器技術的進步（例如精確劑量和安全功能）吸引了醫療保健提供者升級其設備。許多進步已經發布，有助於市場在預測期內的成長。例如，整合到 Zeus 麻醉機中的 Drager DIVA 蒸發器可透過閉迴路定量控制氧氣、載氣和麻醉蒸汽的輸送來實現目標控制麻醉。

此外，手術數量的增加、醫院和診所數量的增加、老年人口的成長以及高醫療保健支出等因素推動了市場的成長。新興國家麻醉蒸發面罩市場需求的增加以及手術設備領域的研發預計將在預測期內創造新的機會。

市場動態：克制

產品召回可能會對麻醉蒸發器市場產生重大影響，因為它們可能導致消費者信心喪失和銷售下降。它們也可能給製造商帶來法律和財務後果。

例如，2021 年 12 月，Getinge 宣佈在全球召回與 Flow Family 麻醉系統的特定七氟烷蒸發器相關的醫療設備。迄今為止，尚未報告患者或操作者發生不良事件。 Getinge 已根據適用法規向相關當局報告，目前正在透過現場安全通知/召回的方式向受影響的客戶通報該問題。此外，設備的高成本和監管挑戰將進一步阻礙預測期內的市場成長率。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按產品類型分類
  • 特定代理的片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 科技進步的崛起
      • 老年人口的增加
    • 限制
      • 產品召回
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按產品類型

  • 靜壓蒸發器
  • 抽屜式汽化器
  • Tec3 汽化器

第 8 章：按特定代理

  • 單一代理
  • 多個代理

第 9 章：最終用戶

  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • GE Healthcare
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Medline
  • NANJING CHENWEI MEDICAL EQUIPMENT CO., LTD.
  • Dolphinmed
  • Conduct Science
  • Penlon
  • Dragerwerk AG & Co. KGaA
  • iClearhealthcare
  • Alnoor Medical
  • Harvard Apparatus

第 13 章：附錄

簡介目錄
Product Code: MD7386

Overview

Anesthesia vaporizers are used to vaporize a liquid anaesthetic agent and deliver a controlled amount to the patient. There are three types of concentration-calibrated vaporisers variable bypass, heated blender, and electronically controlled vapor cassettes. These devices are used in operating rooms, emergency departments, delivery rooms, trauma departments, ambulatory surgical centres, and any areas requiring the administration of an inhalation agent. In the vast majority of cases, vaporizers will be mounted on anaesthesia machines; however, vaporizers can also be associated with cardiopulmonary bypass consoles by the use of special mounting blocks.

Vaporizers are an important part of anesthesia equipment. An understanding of physiology and physics is warranted to ensure the adequate use of these devices. The timely recognition of problems in vaporizer functioning is also essential, as this will decrease the amount of time that patients are potentially exposed to light anesthesia and pain.

Market Dynamics: Drivers and Restraints

Rise in the technological advancements

The rise in the advancements in anaesthesia vaporizer technology, such as precision dosing and safety features, attracts healthcare providers to upgrade their equipment. Many advancements have been released where it helps the market to grow during the forecast period. For example, The Drager DIVA vaporiser which is integrated into the Zeus anaesthesia machine allows for target-controlled anaesthesia with closed-loop quantitative control of the delivery of oxygen, carrier gas and anaesthetic vapour.

Furthermore, factors such as an increase in the number of surgeries, a rise in a number of hospitals and clinics, growth in the geriatric population, and high healthcare expenditure drive the market growth. The increase in demand for anesthesia vaporizer masks market in emerging nations and R&D in the field of surgical equipment is anticipated to create new opportunities during the forecast period.

Market Dynamics: Restraint

Product recalls can have a significant impact on the anesthesia vaporizer market, as they can lead to a loss of consumer confidence and a decrease in sales. They can also result in legal and financial consequences for the manufacturers.

For instance, in December 2021, Getinge stated a global medical device recall related to specific Sevoflurane vaporizers for Flow Family Anesthesia systems. To date, no patient or operator adverse events have been reported. Getinge has reported to relevant authorities according to applicable regulations and is now informing affected customers about the issue through a field safety notice/recall. Also high cost of devices, and regulatory challenges will further hamper the market growth rate during the forecast period.

Segment Analysis

The global anaesthesia vaporizer is segmented based on product type, agent-specific, end-user and region.

The Plenum Vaporizers from the product type segment accounted for approximately 41.2% of the market share

The plenum vaporizers from the product type segment accounted for approximately 41.2% and it is expected to be dominated during the forecast period. Plenum vaporizers are characterized by a pressurized vaporization chamber that generates an increased internal resistance (above atmospheric pressure) for fresh gas flow.

This type of vaporizer is currently the most commonly used and is characterized by its accuracy in the mixture of gases provided to the patient. It is not temperature-compensated. When the control knob, which is just a crude split ratio controller, is in the down position, the cowling over the U-tube descends and brings the FGF closer to the surface of the agent or forces it to bubble through the ether, increasing output by increasing the gas/liquid interface.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the strategic partnerships with key players, improved healthcare infrastructure, product launches by key players and others that will help this region to grow during the forecast period.

For instance, in April 2022, Respirair and Dechra confirmed the US Veterinary Anesthesia Partnership in the USA for isoflurane and sevoflurane veterinary vaporizers and anesthesia accessories. By supplying its market-leading, precision-engineered vaporizers, trolleys and accessories, in conjunction with Dechra's isoflurane and sevoflurane general inhalation anaesthetic agents, the collaboration seeks to create a powerful new force in veterinary anaesthesia coupled with proven, trusted and peerless quality delivery technologies.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global anaesthesia vaporizer market and the COVID-19 pandemic has led to an increased demand for healthcare services, including surgeries and medical procedures, which has boosted the performance of the healthcare sector.

Also, during the pandemic over 20% of coronavirus victims suffered from acute respiratory distress syndrome needing lifesaving therapies in ICUs which led to enormous resource and infrastructure challenges. However, the crisis arguably created the perfect incubator for new ideas and accelerated innovation in anaesthesia vaporizers which helped the market to grow during the forecast period.

Market Segmentation

By Product Type

  • Plenum Vaporizers
  • Drawover Vaporizers
  • Tec3 Vaporizers

By Agent Specific

  • Single Agent
  • Multiple Agents

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the anaesthesia vaporizer market include: GE Healthcare, Medline, Nanjing Chenwei Medical Equipment Co., Ltd., Dolphinmed, Conduct Science, Penlon, Dragerwerk AG & Co. KGaA, iClearhealthcare, Alnoor Medical, Harvard Apparatus and among others.

Key Developments

  • In April 2022, GE Healthcare stated that the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anaesthesia delivery with end-tidal concentration control in the U.S. The company initially released the technology in Europe in 2010 and anesthesia providers use Et Control software to care for patients in over 100 countries.

Why Purchase the Report?

  • To visualize the global anaesthesia vaporizer market segmentation-based product type, agent-specific, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of anaesthesia vaporizer market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global anaesthesia vaporizer market report would provide approximately 61 tables, 57 figures, and 175 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Agent Specific
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Rise in the technology advancements
      • 4.1.1.2. Rise in the geriatric population
    • 4.1.2. Restraints
      • 4.1.2.1. Product Recalls
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Plenum Vaporizers *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Drawover Vaporizers
  • 7.4. Tec3 Vaporizers

8. By Agent Specific

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 8.1.2. Market Attractiveness Index, By Agent Specific
  • 8.2. Single Agent *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Multiple Agents

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Medline
  • 12.3. NANJING CHENWEI MEDICAL EQUIPMENT CO., LTD.
  • 12.4. Dolphinmed
  • 12.5. Conduct Science
  • 12.6. Penlon
  • 12.7. Dragerwerk AG & Co. KGaA
  • 12.8. iClearhealthcare
  • 12.9. Alnoor Medical
  • 12.10. Harvard Apparatus

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us